Clinical Trial Update: Ruxolitinib for Chuvash Polycythemia

View source ↗

Summary

A clinical trial of ruxolitinib for Chuvash polycythemia has become no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chuvash Polycythemia
• Familial Erythrocytosis Type 2

Drugs mentioned

• Ruxolitinib (ruxolitinib)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Erythrocytosis, Familial, 2 | Status: NO_LONGER_AVAILABLE